Bortezomib and High-dose Melphalan at Myeloma Relapse (Q61979644)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib and High-dose Melphalan at Myeloma Relapse |
clinical trial |
Statements
Phase II Study of Bortezomib Dexamethasone and High-dose Melphalan in Patients With Relapse After High-dose Melphalan With Autologous Stem Cell Support (English)
0 references
July 2007
0 references
June 2009
0 references
50
0 references
18 year
0 references